요약정보
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.
- Resource Type
- Academic Journal
- Authors
- Juraska M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Bai H; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817.; deCamp AC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Li L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Gillespie K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Giorgi EE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Ludwig J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Molitor C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Hudson A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Williamson BD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA 98101.; Espy N; Science and Technology Policy Fellowships, American Association for the Advancement of Science, Washington, DC 20005.; Simpkins B; Department of Computer Science, Pitzer College, Claremont, CA 91711.; Rudnicki E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Shao D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Rossenkhan R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Edlefsen PT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Westfall DH; Department of Microbiology, University of Washington School of Medicine, Seattle, WA 98195.; Deng W; Department of Microbiology, University of Washington School of Medicine, Seattle, WA 98195.; Chen L; Department of Microbiology, University of Washington School of Medicine, Seattle, WA 98195.; Zhao H; Department of Microbiology, University of Washington School of Medicine, Seattle, WA 98195.; Bhattacharya T; Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87544.; Pankow A; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Solna 171 77, Sweden.; Murrell B; Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Solna 171 77, Sweden.; Yssel A; Institute of Infectious Disease and Molecular Medicine, and Wellcome Centre for Infectious Diseases Research in Africa, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town 7701, South Africa.; Matten D; Institute of Infectious Disease and Molecular Medicine, and Wellcome Centre for Infectious Diseases Research in Africa, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town 7701, South Africa.; York T; Institute of Infectious Disease and Molecular Medicine, and Wellcome Centre for Infectious Diseases Research in Africa, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town 7701, South Africa.; Beaume N; Institute of Infectious Disease and Molecular Medicine, and Wellcome Centre for Infectious Diseases Research in Africa, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town 7701, South Africa.; Gwashu-Nyangiwe A; Institute of Infectious Disease and Molecular Medicine, and Wellcome Centre for Infectious Diseases Research in Africa, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town 7701, South Africa.; Ndabambi N; Institute of Infectious Disease and Molecular Medicine, and Wellcome Centre for Infectious Diseases Research in Africa, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town 7701, South Africa.; Thebus R; Institute of Infectious Disease and Molecular Medicine, and Wellcome Centre for Infectious Diseases Research in Africa, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town 7701, South Africa.; Karuna ST; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Morris L; HIV Virology Section, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg 2192, South Africa.; Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban 4041, South Africa.; Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, NC 27710.; Hural JA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Cohen MS; Institute of Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.; Corey L; Department of Medicine, University of Washington, Seattle, WA 98195.; Department of Laboratory Medicine, University of Washington, Seattle, WA 98195.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.; Rolland M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817.; Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109.; Department of Biostatistics, University of Washington, Seattle, WA 98195.; Department of Global Health, University of Washington, Seattle, WA 98195.; Williamson C; Institute of Infectious Disease and Molecular Medicine, and Wellcome Centre for Infectious Diseases Research in Africa, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town 7701, South Africa.; Mullins JI; Department of Microbiology, University of Washington School of Medicine, Seattle, WA 98195.; Department of Global Health, University of Washington, Seattle, WA 98195.; Department of Microbiology, University of Washington, Seattle, WA 98109.
- Source
- Publisher:
National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN:00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE - Subject
- Language
- English